Limits...
Awareness regarding clinical application of pharmacogenetics among Japanese pharmacists.

Obara T, Abe S, Satoh M, GutiƩrrez Ubeda SR, Yoshimachi S, Goto T - Pharmgenomics Pers Med (2015)

Bottom Line: Advances in pharmacogenetic analysis technology have accelerated the movement to incorporate pharmacogenetic analysis data into medicine.Available data were collected from 268 pharmacists (male [n=133], <40 years old [n=170], drugstore pharmacists [n=182]).We found a need for actions to improve the awareness of pharmacists about pharmacogenetics and create an environment in which pharmacists are able to provide appropriate medical service based on pharmacogenomic information.

View Article: PubMed Central - PubMed

Affiliation: Department of Pharmacy, Tohoku University Hospital, Sendai, Japan ; Division of Molecular Epidemiology, Environment and Genome Research Center, Tohoku University Graduate School of Medicine, Sendai, Japan ; Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.

ABSTRACT
Advances in pharmacogenetic analysis technology have accelerated the movement to incorporate pharmacogenetic analysis data into medicine. Therefore, pharmacists will soon have to provide guidance and raise pharmaceutical questions regarding prescriptions based on patient pharmacogenomic information. The objective of this study was to clarify Japanese pharmacists' awareness of pharmacogenetics. We conducted a postal questionnaire survey among 372 pharmacists belonging to Tsuruha Holdings. Available data were collected from 268 pharmacists (male [n=133], <40 years old [n=170], drugstore pharmacists [n=182]). Of the pharmacists, 19.0% of the population were aware of the Ethical Guidelines for Human Genome/ Gene Analysis Research in Japan, 31.0% of the population had heard either or both the terms "pharmacogenomics" and "pharmacogenetics", and 16.8% of the population were aware that health insurance covered pharmacogenomic tests performed before prescription in Japan. Only 0.4% indicated that they could raise pharmaceutical questions regarding prescriptions based on patients' pharmacogenomic information, and 61.2% of the population indicated a preference to undertake pharmacogenomic tests to predict the efficacy or adverse reactions of a drug. We found a need for actions to improve the awareness of pharmacists about pharmacogenetics and create an environment in which pharmacists are able to provide appropriate medical service based on pharmacogenomic information.

No MeSH data available.


Awareness of use of insurance-covered pharmacogenomic tests before prescription in Japan.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4325628&req=5

f3-pgpm-8-035: Awareness of use of insurance-covered pharmacogenomic tests before prescription in Japan.

Mentions: A total of 16.8% of the population were aware that health insurance covered pharmacogenomic tests performed before prescription in Japan. Responses to this question did not differ according to sex, age, location of workplace, or duration of employment (Figure 3).


Awareness regarding clinical application of pharmacogenetics among Japanese pharmacists.

Obara T, Abe S, Satoh M, GutiƩrrez Ubeda SR, Yoshimachi S, Goto T - Pharmgenomics Pers Med (2015)

Awareness of use of insurance-covered pharmacogenomic tests before prescription in Japan.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4325628&req=5

f3-pgpm-8-035: Awareness of use of insurance-covered pharmacogenomic tests before prescription in Japan.
Mentions: A total of 16.8% of the population were aware that health insurance covered pharmacogenomic tests performed before prescription in Japan. Responses to this question did not differ according to sex, age, location of workplace, or duration of employment (Figure 3).

Bottom Line: Advances in pharmacogenetic analysis technology have accelerated the movement to incorporate pharmacogenetic analysis data into medicine.Available data were collected from 268 pharmacists (male [n=133], <40 years old [n=170], drugstore pharmacists [n=182]).We found a need for actions to improve the awareness of pharmacists about pharmacogenetics and create an environment in which pharmacists are able to provide appropriate medical service based on pharmacogenomic information.

View Article: PubMed Central - PubMed

Affiliation: Department of Pharmacy, Tohoku University Hospital, Sendai, Japan ; Division of Molecular Epidemiology, Environment and Genome Research Center, Tohoku University Graduate School of Medicine, Sendai, Japan ; Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.

ABSTRACT
Advances in pharmacogenetic analysis technology have accelerated the movement to incorporate pharmacogenetic analysis data into medicine. Therefore, pharmacists will soon have to provide guidance and raise pharmaceutical questions regarding prescriptions based on patient pharmacogenomic information. The objective of this study was to clarify Japanese pharmacists' awareness of pharmacogenetics. We conducted a postal questionnaire survey among 372 pharmacists belonging to Tsuruha Holdings. Available data were collected from 268 pharmacists (male [n=133], <40 years old [n=170], drugstore pharmacists [n=182]). Of the pharmacists, 19.0% of the population were aware of the Ethical Guidelines for Human Genome/ Gene Analysis Research in Japan, 31.0% of the population had heard either or both the terms "pharmacogenomics" and "pharmacogenetics", and 16.8% of the population were aware that health insurance covered pharmacogenomic tests performed before prescription in Japan. Only 0.4% indicated that they could raise pharmaceutical questions regarding prescriptions based on patients' pharmacogenomic information, and 61.2% of the population indicated a preference to undertake pharmacogenomic tests to predict the efficacy or adverse reactions of a drug. We found a need for actions to improve the awareness of pharmacists about pharmacogenetics and create an environment in which pharmacists are able to provide appropriate medical service based on pharmacogenomic information.

No MeSH data available.